Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 111,800 | 172,377 | 299,942 | 66,329 | 50,243 |
| Marketable Securities | 243,425 | 190,885 | 165,115 | 365,343 | 346,019 |
| Receivables | 34,626 | 32,553 | 32,557 | 31,057 | 29,414 |
| Inventories | 7,513 | 6,915 | 6,409 | 6,100 | 6,046 |
| Other current assets | 14,000 | 14,000 | 14,000 | 14,000 | 0 |
| TOTAL | $431,527 | $432,588 | $533,893 | $499,253 | $452,402 |
| Non-Current Assets | |||||
| PPE Net | 302 | 413 | 461 | 633 | 801 |
| Investments And Advances | 59,621 | 0 | 0 | 4,947 | 4,895 |
| Other Non-Current Assets | 102,572 | 91,624 | 83,494 | 78,597 | 75,157 |
| TOTAL | $162,495 | $92,037 | $83,955 | $84,177 | $80,853 |
| Total Assets | $594,022 | $524,625 | $617,848 | $583,430 | $533,255 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 16,710 | 7,976 | 11,216 | 11,976 | 8,178 |
| Accrued Expenses | 21,305 | 18,607 | 53,074 | 28,573 | 13,771 |
| Other current liabilities | 14,000 | 14,000 | 14,000 | N/A | N/A |
| TOTAL | $121,873 | $93,059 | $78,865 | $72,491 | $53,068 |
| Non-Current Liabilities | |||||
| TOTAL | $10,470 | $9,952 | $9,399 | $9,097 | $6,823 |
| Total Liabilities | $132,343 | $103,011 | $88,264 | $81,588 | $59,891 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 103,081 | 102,547 | 101,578 | 107,899 | 107,650 |
| Common Shares | 133 | 132 | 131 | 131 | 130 |
| Retained earnings | 371,171 | 339,793 | 312,265 | 296,386 | 279,785 |
| Other shareholders' equity | -22 | -29 | 340 | -1,017 | -2,382 |
| TOTAL | $461,679 | $421,614 | $529,584 | $501,842 | $473,364 |
| Total Liabilities And Equity | $594,022 | $524,625 | $617,848 | $583,430 | $533,255 |